December 11th, 2017
jobs
homes

Menu
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Kenvue Inc. Common Stock (NY:KVUE)

16.84 +0.76 (+4.73%)
Official Closing Price Updated: 7:00 PM EDT, Oct 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Kenvue Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Which S&P500 stocks are moving on Thursday?
Curious about the top performers within the S&P500 index one hour before the close of the markets on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive... 
Via Chartmill
Stocks Ease, Delta Air Lines, Pepsi Jump On Strong Earnings: What's Moving Markets Thursday?
U.S. stocks edged lower on Thursday, pausing after a record-setting run. The S&P 500 slipped 0.4% by midday in New York, retreating from an all-time high of 5,674 hit at the open. 
Via Benzinga
Discover which S&P500 stocks are making waves on Thursday.
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Thursday. 
Via Chartmill
Kenvue Stock To Face More Headwinds? Trump’s Tylenol Warning Revives Autism Lawsuits, Retail Bulls Stay Unfazed
Via Stocktwits
Topics Government Lawsuit
Why Is Kenvue Stock Rising Premarket Today?
Via Stocktwits
Why Is Kenvue Stock Rising Today?
Via Stocktwits
These Were the 5 Worst-Performing Stocks in the S&P 500 in September 2025 -- and One's Decline Can Be Tied to President Trump
One of these stocks lost about a quarter of its value in a single month. 
Via The Motley Fool
Topics Government Stocks World Trade
Near 52-Week Low, Should You Buy Kenvue Stock?
This beaten-down stock could be an attractive option for long-term investors. 
Via The Motley Fool
Discover which S&P500 stocks are making waves on Tuesday.
Get insights into the S&P500 index performance on Tuesday. Explore the top gainers and losers within the S&P500 index in today's session. 
Via Chartmill
Stocks, Bitcoin Slip, Gold Hits $4,000: What's Moving Markets Tuesday?
Risk sentiment is taking a breather after days of a relentless rally, with all major Wall Street indexes trading in negative territory and sharper declines hitting the most speculative assets, such as... 
Via Benzinga
Exploring the top movers within the S&P500 index during today's session.
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Tuesday. 
Via Chartmill
Why Is Kenvue Stock Falling, and Is It a Buying Opportunity?
Investors are interested in this beaten-down business. 
Via The Motley Fool
Options Corner: Despite Political Woes, Kenvue Can Still Make Tylenol Great Again
While Kenvue's Tylenol has attracted intense political pressure, speculators are determined to make KVUE stock great again. 
Via Benzinga
A Congress Member Sold Up To $330K In UnitedHealth Group Stock: Here's What You Need To Know
 
Via Benzinga
Should You Buy Kenvue Stock After Its 30% Plunge?
There hasn't been much good news lately for this Johnson & Johnson spinoff. 
Via The Motley Fool
Topics Government Lawsuit
Cullen Trims KVUE Stake With $149.5M Share Sale
Via The Motley Fool
Topics Regulatory Compliance
Friday's session: most active stock in the S&P500 index
Looking for the most active S&P500 stocks in today's session? Join us as we dive into the US markets on Friday and discover the stocks that are dominating the trading activity and setting the pace for... 
Via Chartmill
Demystifying Kenvue: Insights From 11 Analyst Reviews
Kenvue (NYSE: KVUE) underwent analysis by 11 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. In the table below, you'll find a summary of their recent ratings,... 
Via Benzinga
White House Highlights A Controversial 2017 Tylenol Tweet On Its Usage During Pregnancy: 'We Actually Don't Recommend...'
A 2017 post by Tylenol on X (formerly Twitter) highlighted by White House has fueled a buzz around President Donald Trump‘s claim that the drug is linked with autism in kids. 
Via Benzinga
Kenvue Bounces Off Record Low: A Deep Dive into its Rebound and Future Prospects
Kenvue (NYSE: KVUE), the consumer health giant spun off from Johnson & Johnson, has experienced a significant rebound in its stock price, climbing notably from a recent record low. This resurgence... 
Via MarketMinute
Topics Government Product Recall
What's going on in today's session: S&P500 movers
Stay informed about the performance of the S&P500 index one hour before the close of the markets on Wednesday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
Wednesday's session: most active stock in the S&P500 index
Looking for the most active S&P500 stocks in today's session? Join us as we dive into the US markets on Wednesday and discover the stocks that are dominating the trading activity and setting the pace... 
Via Chartmill
Kenvue Surges Over 2% Pre-Market Despite Trump Administration's Autism Warning
Kenvue's stock rose 2.61% to $17.69 in pre-market trading on Wednesday, despite concerns sparked by President Trump's comments linking acetaminophen to autism. 
Via Benzinga
Topics Government
Jon Stewart Roasts Trump Over 'Acetaminophen' Pronunciation: 'We Would Like A Second Opinion'
Trump struggles to pronounce acetaminophen while warning pregnant women of its potential link to autism. Jon Stewart mocks his incompetence. 
Via Benzinga
Topics Government
Nvidia, Plug Power, Micron, Kenvue, Kroger: What Sparked Heavy After-Hours Trading In These 5 Stocks?
Micron stock showed a muted reaction to earnings despite the quarterly numbers and guidance exceeding expectations. 
Via Stocktwits
Topics Artificial Intelligence
Trump’s Tylenol Warning Sparks FDA Action, But Kenvue Stock Climbs: Retail Traders See ‘Huge Buying Opportunity’
Kenvue is facing renewed litigation risks, activist investor pressure, and a challenging consumer backdrop as it undertakes a portfolio review under interim CEO Kirk Perry. 
Via Stocktwits
Topics Economy Government Lawsuit
These S&P500 stocks are the most active in today's session
Curious about the most active S&P500 stocks in today's session? Join us as we explore the US markets on Tuesday and uncover the stocks that are leading the way in terms of trading volume and market... 
Via Chartmill
Curious about which S&P500 stocks are generating unusual volume on Tuesday? Find out below.
In today's session, there are S&P500 stocks with remarkable trading volume. Explore the stocks exhibiting unusual volume in Tuesday's session. 
Via Chartmill
What's Going On With Kenvue Stock Tuesday?
Kenvue shares are trading higher Tuesday despite Trump saying the Food and Drug Administration will notify physicians that use of acetaminophen or Tylenol during pregnancy could be associated with... 
Via Benzinga
Topics Government
Kenvue On Track To Bounce Back From Record Lows — What’s Driving Stock Higher In Premarket?
Many doctors reportedly disagreed with the Trump administration’s Tylenol claims and warned that these unfounded claims would likely impair maternal health. 
Via Stocktwits
Topics Government Lawsuit
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.